Please login to the form below
37
Revenue 2017Invega Sustenna/Xeplion/Invega Trinza
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Invega Sustenna/Xeplion/Invega Trinza was produced by Roche.
J&J files three-monthly schizophrenia drug in Europe
J&J sells a once-monthly version of paliperidone as Invega Sustenna in the US and Xeplion in Europe, but the reduced dosing frequency could give the franchise a competitive advantage ... Xeplion/Invega Sustenna is already a big earner for J&J, with sales
FDA approves J&J’s schizophrenia drug Invega Trinza
The FDA has approved Johnson &Johnson's Invega Trinza (three-month paliperidone palmitate) for schizophrenia. ... Invega Sustenna, which is marketed as Xeplion in Europe, saw its 2014 sales grow by 27% to $1.6bn and J&J will be hopig Invega Trinza will
1
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Octapharma cleared to start phase 3 trial of Octagam in COVID-19
- UK’s new COVID-19 trial initiative fast-tracks BerGenBio’s bemcentinib
- NHS England will make PrEP for HIV available in April
- Gilead, Galapagos dip on mixed ulcerative colitis data
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Oxford University Press advertising and custom content team hosts their first ever virtual drop-in sessions
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- Merck buys Themis as part of drive for COVID-19 drugs and vaccines
- FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC
- Now is the time to show just how valuable this industry is to the UK
- COVID-19: the race to find a vaccine
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- COVID-19: the race to find a vaccine
- How biopharma is working to bring an end to the pandemic...
- Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
- Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...
- ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
- The art of delivering valuable customer journeys aligned to your key messages in 2020...
Quick links
Infographics
